Shopping Cart
- Remove All
- Your shopping cart is currently empty
LR-90, an advanced glycation end product (AGE) inhibitor, is utilized in diabetic animal model research. This compound effectively suppresses inflammatory responses in human monocytes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $37 | In Stock | |
5 mg | $88 | In Stock | |
10 mg | $148 | In Stock | |
25 mg | $263 | In Stock | |
50 mg | $392 | In Stock | |
100 mg | $572 | In Stock | |
200 mg | $768 | In Stock | |
1 mL x 10 mM (in DMSO) | $137 | In Stock |
Description | LR-90, an advanced glycation end product (AGE) inhibitor, is utilized in diabetic animal model research. This compound effectively suppresses inflammatory responses in human monocytes. |
In vitro | LR-90 (0, 25, 50, 100, and 200 μM) significantly blocks THP-1 cell adherence to endothelial cells in a dose-dependent manner after 1-hour pretreatment followed by S100b stimulation for 24 hours, without affecting THP-1 cell viability. Additionally, LR-90 inhibits RAGE, MCP-1, COX-2, IP-10, and NOX2 mRNA expression in THP-1 cells dose-dependently after 1-hour pretreatment before S100b stimulation for 4 hours[1]. |
In vivo | LR-90 (50 mg/L) decreases renal AGE, AGER and lipid peroxidation[2].LR-90 (50 mg/L, p.o. for 27 weeks) significantly reduces plasma lipids, modestly affects hyperglycaemia in ZDF rats[2]. |
Molecular Weight | 709.57 |
Formula | C35H34Cl2N4O8 |
Cas No. | 245075-84-7 |
Smiles | CC(C)(Oc1ccc(NC(=O)Nc2ccc(Cc3ccc(NC(=O)Nc4ccc(OC(C)(C)C(O)=O)cc4)c(Cl)c3)cc2Cl)cc1)C(O)=O |
Relative Density. | 1.448 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 95 mg/mL (133.88 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.